Biotechnological Company Pays $2.9 Million Settlement
April 17, 2013
– ATTORNEY NEWSLETTER – Amgen, Inc., a California-based biotechnology company, agrees to pay a $2.9 million settlement after allegations of marketing their products to patients who did...